AMMONUL (SODIUM BENZOATE; SODIUM PHENYLACETATE) — FDA Approval NDA020645 (BAUSCH)
AMMONUL (SODIUM BENZOATE; SODIUM PHENYLACETATE) — FDA Approval NDA020645 (BAUSCH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AMMONUL; Active ingredients: SODIUM BENZOATE; SODIUM PHENYLACETATE; Application number: NDA020645.
| Brand name | AMMONUL |
|---|---|
| Active ingredients | SODIUM BENZOATE; SODIUM PHENYLACETATE |
| Application number | NDA020645 |
| Sponsor | BAUSCH |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20050217 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →